ETF Holdings Breakdown of CLBT

CLBT institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-10-15	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	75,099	USD 1,449,411
2025-10-15	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	652	USD 12,584
Total =		75,751	USD 1,461,995

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with CLBT

Cellebrite DI Ltd. (NASDAQ:CLBT) Receives $22.40 Average PT from Brokerages

Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) has been given a consensus recommendation of “Buy” by the five research firms that are presently covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy rating. The average 1 year price objective among brokers that have covered the stock […] - 2025-09-17 02:42:45

Cellebrite DI Ltd. (NASDAQ:CLBT) Given Consensus Rating of “Buy” by Brokerages

Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) has earned a consensus recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have issued ratings on the stock in […] - 2025-08-20 02:38:43

Company News for Aug 15, 2025

Companies In The News Are: DE, DLO, AMCR, CLBT. - 2025-08-15 03:44:00

Natixis Advisors LLC Takes $469,000 Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

Natixis Advisors LLC bought a new stake in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) in the 1st quarter, Holdings Channel.com reports. The firm bought 24,131 shares of the company’s stock, valued at approximately $469,000. Other institutional investors and hedge funds have also made changes to their positions in the company. Assetmark Inc. purchased a […] - 2025-08-12 04:38:46

Cellebrite DI (NASDAQ:CLBT) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut shares of Cellebrite DI (NASDAQ:CLBT – Free Report) from a buy rating to a hold rating in a research report report published on Saturday. A number of other brokerages have also weighed in on CLBT. JPMorgan Chase & Co. dropped their price target on Cellebrite DI from $29.00 to $25.00 and […] - 2025-08-05 02:13:00

Teacher Retirement System of Texas Acquires 24,337 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)

Teacher Retirement System of Texas grew its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 121.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 44,407 shares of the company’s stock after buying an additional 24,337 shares during […] - 2025-07-15 05:09:26

OneDigital Investment Advisors LLC Has $556,000 Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

OneDigital Investment Advisors LLC increased its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 2.5% during the 1st quarter, Holdings Channel.com reports. The fund owned 28,591 shares of the company’s stock after acquiring an additional 688 shares during the period. OneDigital Investment Advisors LLC’s holdings in Cellebrite DI were worth $556,000 […] - 2025-07-10 06:04:47

Calamos Advisors LLC Decreases Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

Calamos Advisors LLC trimmed its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 63.9% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 38,642 shares of the company’s stock after selling 68,337 shares during the period. Calamos Advisors LLC’s holdings in […] - 2025-07-07 05:58:55

Brokerages Set Cellebrite DI Ltd. (NASDAQ:CLBT) Price Target at $22.43

Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) have received a consensus rating of “Buy” from the seven research firms that are currently covering the company, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have issued ratings on […] - 2025-07-04 02:22:50

Robeco Institutional Asset Management B.V. Invests $3.84 Million in Cellebrite DI Ltd. (NASDAQ:CLBT)

Robeco Institutional Asset Management B.V. purchased a new stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 197,554 shares of the company’s stock, valued at approximately $3,838,000. Robeco Institutional Asset […] - 2025-07-01 05:32:54

Manning & Napier Advisors LLC Makes New Investment in Cellebrite DI Ltd. (NASDAQ:CLBT)

Manning & Napier Advisors LLC acquired a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) in the first quarter, Holdings Channel reports. The fund acquired 101,848 shares of the company’s stock, valued at approximately $1,979,000. Other hedge funds also recently added to or reduced their stakes in the company. Gen Wealth […] - 2025-06-24 05:46:49

Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 32.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 148,132 shares of the company’s stock […] - 2025-06-06 05:16:58

Cellebrite DI Ltd. (NASDAQ:CLBT) Given Average Recommendation of “Buy” by Brokerages

Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) have been given an average rating of “Buy” by the seven research firms that are currently covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued ratings on the stock […] - 2025-06-06 02:54:54

Mackenzie Financial Corp Invests $776,000 in Cellebrite DI Ltd. (NASDAQ:CLBT)

Mackenzie Financial Corp purchased a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 35,217 shares of the company’s stock, valued at approximately $776,000. Other large investors also recently made changes to their positions in the company. Raymond James Financial Inc. bought […] - 2025-06-02 05:48:55

Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Purchased by Bank of America Corp DE

Bank of America Corp DE raised its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 32.0% in the 4th quarter, HoldingsChannel reports. The fund owned 680,375 shares of the company’s stock after acquiring an additional 165,116 shares during the period. Bank of America Corp DE’s holdings in Cellebrite DI were worth $14,989,000 at […] - 2025-05-22 05:30:55

Needham & Company LLC Issues Pessimistic Forecast for Cellebrite DI (NASDAQ:CLBT) Stock Price

Cellebrite DI (NASDAQ:CLBT – Get Free Report) had its price objective lowered by investment analysts at Needham & Company LLC from $28.00 to $24.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s price objective would suggest a potential upside […] - 2025-05-16 04:59:11

Cellebrite DI (NASDAQ:CLBT) Shares Gap Down After Analyst Downgrade

Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report)’s stock price gapped down prior to trading on Wednesday after Needham & Company LLC lowered their price target on the stock from $28.00 to $24.00. The stock had previously closed at $20.12, but opened at $16.91. Needham & Company LLC currently has a buy rating on the […] - 2025-05-16 02:16:56

JPMorgan Chase & Co. Lowers Cellebrite DI (NASDAQ:CLBT) Price Target to $25.00

Cellebrite DI (NASDAQ:CLBT – Free Report) had its target price cut by JPMorgan Chase & Co. from $29.00 to $25.00 in a research report sent to investors on Monday morning,Benzinga reports. They currently have an overweight rating on the stock. A number of other research firms have also weighed in on CLBT. Needham & Company […] - 2025-05-15 02:44:43

CLBT Makes Notable Cross Below Critical Moving Average

In trading on Wednesday, shares of Cellebrite DI Ltd (Symbol: CLBT) crossed below their 200 day moving average of $18.99, changing hands as low as $16.60 per share. Cellebrite DI Ltd shares are currently trading down about 12.9% on the day. The chart below shows the one year p - 2025-05-14 12:56:46

Notable ETF Inflow Detected - SCZ, TIGO, ODD, CLBT

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI EAFE Small-Cap ETF (Symbol: SCZ) where we have detected an approximate $243.5 million dollar inflow -- that's a 2.6% increase week over - 2025-05-09 11:54:18

NewEdge Advisors LLC Has $86,000 Stock Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

NewEdge Advisors LLC increased its stake in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 600.7% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 3,910 shares of the company’s stock after purchasing an additional 3,352 shares during the quarter. NewEdge Advisors LLC’s holdings in Cellebrite DI were worth $86,000 as of its most […] - 2025-05-04 05:42:48

Noteworthy ETF Outflows: SCZ, CLBT, ODD, INMD

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI EAFE Small-Cap ETF (Symbol: SCZ) where we have detected an approximate $172.9 million dollar outflow -- that's a 1.8% decrease week ove - 2025-05-01 12:46:40

Head to Head Analysis: Cellebrite DI (NASDAQ:CLBT) versus Intellicheck (NYSE:IDN)

Intellicheck (NYSE:IDN – Get Free Report) and Cellebrite DI (NASDAQ:CLBT – Get Free Report) are both industrials companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, analyst recommendations, profitability and institutional ownership. Analyst Ratings This is a summary of current ratings […] - 2025-04-24 02:28:50

Legal & General Group Plc Purchases 36,949 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)

Legal & General Group Plc boosted its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 30.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 160,223 shares of the company’s stock after buying an additional 36,949 shares during the period. Legal & […] - 2025-04-23 05:21:01

JPMorgan Chase & Co. Has $7.31 Million Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)

JPMorgan Chase & Co. trimmed its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 22.4% in the 4th quarter, Holdings Channel reports. The institutional investor owned 331,665 shares of the company’s stock after selling 95,990 shares during the period. JPMorgan Chase & Co.’s holdings in Cellebrite DI were worth $7,307,000 as […] - 2025-04-17 04:27:15

Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Acquired by Sei Investments Co.

Sei Investments Co. increased its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 43.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 408,043 shares of the company’s stock after buying an additional 124,558 shares during the quarter. […] - 2025-03-31 04:48:59

Noteworthy ETF Inflows: SCZ, ZIM, CLBT, ODD

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI EAFE Small-Cap ETF (Symbol: SCZ) where we have detected an approximate $390.8 million dollar inflow -- that's a 4.4% increase week over - 2025-03-24 12:51:29

Cellebrite DI (NASDAQ:CLBT) Receives Buy Rating from Needham & Company LLC

Cellebrite DI (NASDAQ:CLBT – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Needham & Company LLC in a note issued to investors on Monday,Benzinga reports. They currently have a $28.00 target price on the stock. Needham & Company LLC’s price objective suggests a potential upside of 62.51% from the stock’s […] - 2025-03-12 04:08:56

Principal Financial Group Inc. Sells 334,666 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)

Principal Financial Group Inc. reduced its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 24.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,054,988 shares of the company’s stock after selling 334,666 shares during the quarter. Principal Financial Group Inc.’s […] - 2025-02-24 06:50:55

Cellebrite DI (NASDAQ:CLBT) Receives Buy Rating from Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of Cellebrite DI (NASDAQ:CLBT – Free Report) in a research note released on Friday,Benzinga reports. They currently have a $28.00 price target on the stock. CLBT has been the subject of several other reports. Craig Hallum upped their price target on shares of Cellebrite DI […] - 2025-02-17 06:42:58

Back to Listing

Disclaimer